Back
LENZ Therapeutics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
24
LENZ
LENZ Therapeutics, Inc.
Last Price:
$27.85
Seasonality Move:
-9.52%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiLENZ Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, LENZ Therapeutics, Inc. has on average historically risen by 2.2% based on the past 4 years of stock performance.
-
LENZ Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is LENZ Therapeutics, Inc. Stock Undervalued?The current LENZ Therapeutics, Inc. [LENZ] share price is $27.90. The Score for LENZ is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
LENZ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will LENZ Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, LENZ Therapeutics, Inc. has on average historically risen by 2.2% based on the past 4 years of stock performance.
LENZ Therapeutics, Inc. Stock Rating
Sell
24
LENZ Therapeutics, Inc. (LENZ)
is a Sell
Is LENZ Therapeutics, Inc. overpriced?
-
LENZ Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
LENZ Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
lenz-tx.com
52-Week Data
52-Week High:
50.40
52-Week Low:
16.54
Prediction Charts
Market Cap:
873M
Price in USD:
27.90
Volume:
499K
Beta:
0.47
Technical Analysis
SMA50:
33.78
SMA100:
35.42
SMA200:
31.15
52-Wk Change:
-22.13%
Stock Predictions
-
Is LENZ Therapeutics, Inc. stock public?Yes, LENZ Therapeutics, Inc. is a publicly traded company.
-
What is the LENZ Therapeutics, Inc. stock quote today?The LENZ Therapeutics, Inc. stock price is 27.90 USD today.
-
How to buy LENZ Therapeutics, Inc. stock online?You can buy LENZ Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 26.17 | 25.60 | 26.23 | 25.00 |
| Nov-17 | 25.56 | 25.70 | 26.92 | 25.00 |
| Nov-18 | 25.38 | 27.23 | 27.34 | 25.02 |
| Nov-19 | 27.29 | 28.40 | 29.02 | 26.80 |
| Nov-20 | 28.52 | 27.72 | 29.80 | 27.67 |
| Nov-21 | 27.69 | 29.56 | 30.25 | 27.44 |
| Nov-24 | 29.54 | 31.94 | 32.13 | 28.93 |
| Nov-25 | 31.60 | 29.88 | 32.10 | 29.72 |
| Nov-26 | 30.29 | 30.72 | 31.87 | 30.01 |
| Nov-28 | 30.72 | 30.52 | 31.58 | 30.19 |
| Dec-1 | 30.00 | 30.40 | 30.80 | 29.54 |
| Dec-2 | 30.13 | 27.31 | 30.78 | 27.07 |
| Dec-3 | 27.63 | 28.00 | 28.76 | 27.60 |
| Dec-4 | 27.88 | 27.90 | 29.02 | 27.65 |
LENZ Therapeutics, Inc. Earnings
LENZ Therapeutics, Inc. Earnings Report: Per Share LENZ Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
LENZ Therapeutics, Inc. Forecast Revenue Growth
LENZ Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for LENZ Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.18 per share.
* LENZ Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.